Shared ambitions in artificial intelligence
United by a shared vision, both Guerbet and Intrasense aim to become leaders in medical imaging Artificial Intelligence (AI) applied to medical imaging, integrating expert tools into radiologists' clinical routines.
This ambition underscores our mutual commitment to redefining the boundaries of medical imaging, harnessing technological leeps to deliver innovative healthcare solutions for medical imaging professionals.
Our alliance is focused on creating value and enhancing medical imaging solutions, with a unique mandate: to help save lives.
Alexandre Salvador, CEO of Intrasense, and François Nicolas, R&D Director at Guerbet and Chairman of the Board of Directors of Intrasense, present the ambitions:
Intrasense, French medtech innovator in medical imaging
A French expert in medical imaging since 2004, Intrasense develops and markets software platforms that facilitate and secure diagnosis, decision-making and therapeutic follow-up.
Developer of Myrian® and Liflow®, Intrasense enhances its solutions with the integration of AI algorithms. Its teams work closely with healthcare professionals to help save lives.
Alliance of French players with an international dimension
Intrasense, has integrated advanced tools into medical imaging software solutions for 20 years, building on ability to orchestrate clinical workflow for radiologists. Intrasense is known for this expertise, to integrate Artificial Intelligence algorithms into solutions and thus complete product offering.
Since June 2023, Guerbet is Intrasense shareholder, making it a subsidiary of the Group and sealing our strategic alliance to serve oncology medical imaging.
This technical and operational collaboration will see many projects come to fruition very quickly, offering new AI enhanced solutions to medical imaging professionals, to help saves lives.